Richard Heyman - Director, Oric Pharmaceuticals, Inc

As of September 16, 2021


Richard Heyman Net Worth

  • Net worth is estimated to be at least $5.1M
  • Owns at least 228,772 units of Oric Pharmaceuticals, Inc stock
  • Sold an estimated value of $282.92K in the last year at Oric Pharmaceuticals, Inc

Richard Heyman Trading

  • Largest sale of shares was 5,874 units , worth over $148.58K on May 18, 2021
  • In total has made about 11 transactions over a year
  • Usually trades in April, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Richard Heyman Mailing Address

  • Mailing address is 5871 Oberlin Drive, Suite 150 San Diego CA 92121 CA

Oric Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Jacob M. Chacko, M.D. 2020 $489,167 $300,800 $300,800 $988 $5,873,786
Jacob M. Chacko, M.D. 2019 $455,833 $194,900 $194,900 $21,396 $672,129
Jacob M. Chacko, M.D. 2018 $290,000 $92,800 $92,800 $57,897 $1,635,139
Dominic Piscitelli 2020 $380,833 $187,400 $187,400 $606 $1,570,883
Dominic Piscitelli 2019 $115,144 $38,300 $38,300 $111 $1,236,705
Dominic Piscitelli 2018 - - - - -
Pratik Multani, M.D. 2020 $416,667 $205,000 $205,000 $621 $2,335,928
Pratik Multani, M.D. 2019 $398,333 $132,400 $132,400 $4,423 $535,156
Pratik Multani, M.D. 2018 $112,500 $27,000 $27,000 $25,876 $490,144
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1796280/000119312521130074/d127916ddef14a.htm

Oric Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 1,388 units sold on September 16, 2021 by Richard Heyman worth over $34.76K
  • In the last year, insiders at Oric Pharmaceuticals, Inc sold an estimated value of $32.41M and bought an estimated value of $9M
  • The most active traders are Jacob Chacko, President and CEO,  Richard Heyman, Director,  and Carl Gordon, Director
  • Insider trading is most common in April, with the busiest year in 2021

Oric Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1